Bank of America closes the week at $54.42 — a fresh post-April high — with short sellers showing the first signs of hesitation after five consecutive weeks of rebuilding.
The short interest story has shifted in the two days since the previous note. After peaking at 116 million shares on June 5 and pushing the SI % of Free Float to 1.64%, the short book pulled back modestly — ending June 9 at 113.9 million shares, or 1.56% of float. That is still up 12.9% on the week and 13.8% on the month, confirming the rebuild trend documented in the prior report remains intact. But the two-day dip is notable: it coincides precisely with the stock's push above $54, suggesting some shorts covered into the rally rather than pressing. The borrow market offers no constraint either way. Availability is extraordinarily loose at over 7,600% — meaning the lending pool dwarfs the current short book by orders of magnitude — and cost to borrow has fallen sharply, down 37% on the week to just 0.27%. These are not conditions that force short covering. The pullback looks voluntary.
Options positioning has also normalised after an elevated mid-week reading. The put/call ratio closed at 1.28 on June 9, almost exactly in line with its 20-day average of 1.27 and a z-score near zero — well off the more defensive readings of 1.50 and 1.52 seen earlier in the week. The banking sector broadly moved with BAC: gained 3.2% on the week, rose 3.9%, and led the group with a 4.5% advance. BAC's 3.7% weekly gain sits in the middle of that pack — no longer the laggard flagged in earlier peer notes, but not leading either.
The Street remains constructive, though the most recent analyst activity dates from mid-April following Q1 results. At that point, every firm in the coverage universe that moved did so by raising targets — Jefferies to $65, KBW to $64, Oppenheimer and Truist both to $61. The consensus mean price target of $63.16 implies roughly 16% further upside from current levels. With the stock now at $54.42, BAC is trading through several of the post-Q1 targets that looked stretched at the time. The price-to-book multiple has expanded 0.08x over the past 30 days to 1.31x — modest re-rating rather than a valuation stretch. The earnings quality factors support the bull case: EPS surprise ranks in the 75th percentile, 90-day EPS momentum in the 80th. The dividend score, at the 95th percentile, underlines the yield support that anchors long holders in any pullback.
Insider activity tells a routine rather than alarming story. CEO Brian Moynihan's recurring quarterly sell programme — awards immediately followed by same-size sales — continued in May at $49.77 per share. Chief Risk Officer Geoffrey Greener sold 126,756 shares in early May for roughly $6.7 million, the largest single discretionary sale in the recent record. Net insider activity over 90 days shows a small positive share count of 939,000 shares, almost entirely driven by the award-and-sell mechanics. There is no cluster of open-market buying or concentrated selling outside the structured programmes.
Q2 earnings land on July 14. Between now and then, the question is whether the short rebuild resumes — testing the April highs of 116 million shares — or fades again as the stock approaches analyst target prices, and whether options traders begin to reload downside protection as the print gets closer.
See the live data behind this article on ORTEX.
Open BAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
